Pharmabridge Inc - 18902 Doylestown, PA

Business Name: Pharmabridge Inc
Categorized In: Research and Development Laboratories
Address: 3805 Old Easton Road, Doylestown, PA 18902
Phone Number: (215) 589-6350
Contact Person: Xiaodong Xu
Website Address: pabiotechbc.org
NAICS Code: 541712
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2006
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Gfree Bio LLC - Doylestown, PA 18902
Shar-X Biopharma LLC - Doylestown, PA 18902
Fox Chase Chem Diversity Center - Doylestown, PA 18902
Clinical Mobilty Technology - Doylestown, PA 18902
Alliance Discovery Inc - Doylestown, PA 18902
Serome Biosciences - Doylestown, PA 18902
Zasloff Laboratories - Doylestown, PA 18902
Toph Biologicals Inc - Doylestown, PA 18902
Alis Life Science LLC - Doylestown, PA 18902
Als Biopharma LLC - Doylestown, PA 18902
Captivate Pharmaceuticals - Doylestown, PA 18902
Jiffy Lid Technologies LLC - Doylestown, PA 18902
Pennsylvania Drug Discovery Institute - Doylestown, PA 18902
Cherry Pharmaceutical - Doylestown, PA 18902
Jbs Science Inc - Doylestown, PA 18902
Immunotope Diagnostics Inc - Doylestown, PA 18902
Enantigen Therapeutics Inc - Doylestown, PA 18902

Pharmabridge Inc provides professional Research and Development Laboratories from its single location at the coordinates 40.333189,-75.12617.

The company offers B2B variables under the SIC code 8731 and NAICS code 541712, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2006, the company can now be visited at 3805 Old Easton Road, Doylestown, Pennsylvania 18902 or contacted through representative Xiaodong Xu at (215) 589-6350.

For frequently asked questions and further inquiries about professional Research and Development Laboratories, get to know more about Pharmabridge Inc through its company website at pabiotechbc.org. Engage with this business on its social media platforms through on Twitter and on Facebook.